Commander of an Immune Flotilla

With much of his early career dictated by US Navy interests, Carl June drew inspiration from malaria, bone marrow transplantation, and HIV in his roundabout path to a breakthrough in cancer immunotherapy.

Written byJef Akst
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

CARL H. JUNE
Director of Translational Research,
Abramson Cancer Center
Richard W. Vague Professor in Immunotherapy Department of Pathology and Laboratory Medicine Perelman School of Medicine,
University of Pennsylvania
COURTESY OF UNIVERSITY OF PENNSYLVANIA
In 1971, as Carl June geared up to graduate from his San Francisco Bay–area high school, the Vietnam War raged on. He had been accepted to Stanford University, Caltech, and others, but with the risk of being drafted into the already decade-long war, June opted to attend the United States Naval Academy (USNA) in Annapolis, Maryland, “with the rationale that it would make me an officer, rather than going in as an enlisted person into the rice paddies,” he says.

A year earlier, the school had launched its premed program. With a knack for biology, June jumped on the opportunity, joining 15 others in the second USNA premed class. More good fortune struck when the U.S. pulled its troops out of Vietnam in 1973, “so when I graduated there was no longer a war, which I was happy about,” June recalls. Rather than sending him overseas, the Navy gave June a full ride to medical school at Baylor College of Medicine in Texas, where he completed the required coursework in three years. He then jetted off to Geneva, Switzerland, to join a lab conducting research on malaria vaccines at the World Health Organization for the fourth year of his scholarship. “My last year [of med ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies